Tech titans are hacking their bodies for a longer life: is there science behind their methods?

Tech executives and wealthy individuals are actively exploring and sharing methods to extend human lifespan, a trend documented in a publication by Nature on June 16, 2026. These individuals, often referred to as "biohackers," are experimenting with various interventions, including dietary changes, supplements, and advanced medical technologies. The article highlights a growing interest in longevity research driven by figures in the technology sector who are investing heavily in companies and research focused on anti-aging. Specific practices discussed include intermittent fasting, which some proponents claim can activate cellular repair mechanisms, and the use of nootropics, substances intended to enhance cognitive function. Furthermore, the piece touches upon more experimental approaches such as gene therapy and the potential use of senolytics, drugs designed to clear out aging cells. While the pursuit of extended life is gaining traction among this demographic, the scientific validation for many of these methods remains under investigation, with researchers emphasizing the need for rigorous clinical trials to confirm efficacy and safety. The trend reflects a broader societal fascination with longevity and the potential for scientific breakthroughs to significantly alter human healthspan and lifespan.